PredicTx Health
Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.
Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.
PredicTx expands clinical trial from Australia to India and the Middle East while working towards TGA approval and CE marking.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.